Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart Failure ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- [2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].Kardiol Pol. 2015; 73: 1127-1206
- Stressing the Cardiopulmonary Vascular System: The Role of Echocardiography.J Am Soc Echocardiogr. 2018; 31: 527-550.e11
- Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology.Eur J Heart Fail. 2016; 18: 226-241
- Relevant issues in the pathology and pathobiology of pulmonary hypertension.J Am Coll Cardiol. 2013; 62: D4-D12
- Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.Am J Respir Crit Care Med. 2012; 186: 790-796
- [Anabolic/catabolic imbalance in chronic heart failure].Monaldi Arch Chest Dis. 2010; 74: 53-56
- Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry.Intern Emerg Med. 2018; 13: 661-671
- Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency.J Clin Endocrinol Metab. 1993; 77: 1658-1661
- Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction.Int J Cardiol. 2016; 225: 1-3
- Exercise Intolerance in Heart Failure with Preserved Ejection Fraction.Heart Failure Clin. 2021; 17: 397-413
- The GH/IGF-1 axis in chronic heart failure.Endocr Metab Immune Disord Drug Targets. 2013; 13: 76-91
- IGF-1 predicts survival in chronic heart failure. Insights from the T.O.S.CA. (Trattamento Ormonale Nello Scompenso CArdiaco) registry.Int J Cardiol. 2014; 176: 1006-1008
- Multiple hormone deficiency syndrome: a novel topic in chronic heart failure.Future Sci. 2018; 4: FSO311
- Growth hormone replacement delays the progression of chronic heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-blind study.JACC Heart Fail. 2013; 1: 325-330
- Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction.J Clin Endocrinol Metab. 2009; 94: 3329-3336
- Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study.J Am Coll Cardiol. 2010; 56: 1310-1316
- Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension.Respir Res. 2021; 22: 288
- Pulmonary arterial hypertension-related myopathy: an overview of current data and future perspectives.Nutr Metab Cardiovasc Dis. 2015; 25: 131-139
- Exercise stress echocardiography for the study of the pulmonary circulation.Eur Respir J. 2010; 35: 1273-1278
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).Eur Heart J. 2016; 37: 67-119
- Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.Am J Respir Crit Care Med. 2009; 179: 151-157
- Five-Year outcomes of patients enrolled in the REVEAL Registry.Chest. 2015; 148: 1043-1054
- Imaging the heart in pulmonary hypertension: an update.Eur Respir Rev. 2015; 24: 653-664
- Addressing the Controversy of Estimating Pulmonary Arterial Pressure by Echocardiography.J Am Soc Echocardiogr. 2016; 29: 93-102
- The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension.J Am Coll Cardiol. 2017; 69: 236-243
- Prognostic value of cardiac magnetic resonance imaging for idiopathic pulmonary arterial hypertension before initiating intravenous prostacyclin therapy.Circ J. 2012; 76: 1737-1743
- Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension.Circulation. 2010; 122: 920-927
- Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.Ann Am Thorac Soc. 2016; 13: 25-30
- Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension.Am J Respir Cell Mol Biol. 2014; 50: 74-86
- Role of the ubiquitin proteasome system in the heart.Circ Res. 2013; 112: 1046-1058
- Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species.Am J Physiol Regul Integr Comp Physiol. 2008; 294: R673-R680
- The Akt kinase signals directly to endothelial nitric oxide synthase.Curr Biol. 1999; 9: 845-848
- The Role of Hyperglycemia and Insulin Resistance in the Development and Progression of Pulmonary Arterial Hypertension.J Diabetes Res. 2016; 2016: 2481659
- IGF-1 induces iNOS expression via the p38 MAPK signal pathway in the anti-apoptotic process in pulmonary artery smooth muscle cells during PAH.J Recept Signal Transduct Res. 2014; 34: 325-331
- Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension.Eur Respir J. 2018; 51https://doi.org/10.1183/13993003.00467-2018
- Characterization of the vasodilatory action of testosterone in the human pulmonary circulation.Vasc Health Risk Manag. 2008; 4: 1459-1466
- Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension.Eur J Med Res. 2009; 14: 433-442
- Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry.Eur J Prev Cardiol. 2021; https://doi.org/10.1093/eurjpc/zwab020
- Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic action.J Cardiovasc Pharmacol. 2002; 39: 814-823
- Growth Hormone Deficiency Is Associated with Worse Cardiac Function, Physical Performance, and Outcome in Chronic Heart Failure: Insights from the T.O.S.CA. GHD Study.PLoS One. 2017; 12: e0170058
- Klinefelter syndrome, cardiovascular system, and thromboembolic disease: review of literature and clinical perspectives.Eur J Endocrinol. 2016; 175: R27-R40
- The association of heart failure with insulin resistance and the development of type 2 diabetes.Am J Hypertens. 2005; 18: 731-737
- Metabolic impairment in heart failure: the myocardial and systemic perspective.J Am Coll Cardiol. 2014; 64: 1388-1400
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
